BNET Industries
Market Cap:$3.0M
Last Fiscal Year Sales:$19.2M
- Public
- US
Dow Jones Description
Mfr, Developer & Marketer of Veterinary Diagnostics, Vaccines & Other Animal Health Related Products
President and CEO
Paul R. HaysNumber of Employees 100
Contact Information
12200 NW Ambassador Dr Ste 101
Kansas City, Missouri 64163
(858) 464-3500
Peer Companies
NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413
News & Analysis
Filter by
investment and synbiotics corp. - All News and Analysis
Daou, Synbiotics Forced to Delist From Nasdaq
- 2001-05-07
Finance: Firms Tend to Downplay Significance as Impacts Hard to Pinpoint While companies downplay its significance, getting delisted from a major stock exchange like the Nasdaq is something they try to avoid. Recently, two San Diego firms were delisted from Nasdaq, when the shares of both firms dropped...
Synbiotics Corp. signs agreement to acquire International Canine Genetics Inc
- 1996-07-25
SAN DIEGO--BUSINESS WIRE--July 25, 1996--Synbiotics Corp. (NASDAQ:SBIO) and Malvern, Pa.-based International Canine Genetics Inc. (OTC Bulletin Board:ICGI;ICGIW), Thursday announced they have signed a definitive agreement under which International Canine Genetics ICG will be acquired by Synbiotics.The acquisition is subject to certain regulatory and stockholder approvals.Under the terms of the agreement,...
Synbiotics Corp. to receive additional shares in Texas Biotechnology Corp
- 1995-07-25
SAN DIEGO--BUSINESS WIRE--July 25, 1995--Synbiotics Corp. (NASDAQ:SBIO) Tuesday reported that it will receive an additional 573,109 shares in Texas Biotechnology Corp. TBC, a Houston-based biopharmaceutical company.In July 1994, Synbiotics' then-41-percent-owned affiliate ImmunoPharmaceutics Inc. IPI was merged with TBC. Pursuant to the merger agreement, TBC announced Tuesday that IPI has...
Synbiotics posts modest profit; offering awaits SEC's approval
- 1987-04-27
Synbiotics posts modest profit; offering awaits SEC's approval Synbiotics Corp. finds itself in its strongest financial position ever while awaiting approval from the Securities and Exchange Commission for a public offering of 1.25 million shares of common stock. Revenues for the San Diego biomedical company for the year...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Paul R. Hays | President and CEO |
| Keith A. Butler | Cfo |
| B. Kent Luther | Vice President, Sales & Marketing |
| Chinta Lamichhane | Vice President, R & D |
| Clifford Frank | Vice President, Strategic Projects |
| Michael Harrod | Director of Technical Resources |
| Christophe Calleja | Marketing Manager |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Donald E Phillips | Chairman of the Board of Directors |
| Christopher P. Hendy | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | President and CEO | Current |
| Synbiotics Europe S.A.S. | President | Current |
| Synbiotics Corporation | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Cfo | Current |
| Synbiotics Corporation | Vice President | Current |
| Synbiotics Corporation | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, R & D | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Vice President, Strategic Projects | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Director of Technical Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Synbiotics Corporation | Marketing Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Finds Ammonia | Current | |
| Synbiotics Corporation | Chairman of the Board of Directors | Current |
| Mississippi.Com | President | Former |
| Organization | Position | Status |
|---|---|---|
| Redwood Holdings, Inc. | Current | |
| Schonstedt Instrument Company | Board of Directors | Current |
| Synbiotics Corporation | Board of Directors | Current |
| Marine Midland Bank | Former | |
| Xavier University | B.S. Degree In Business Administration | Former |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
